Source: Annual Congress 2004 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. V. Martynyuk, N. A. Mironova, I. Y. Chazova (Moscow, Russia). Renin-angiotensin-aldosterone system activation in different vasculature areas in primary pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 141

Member's Comments

No comment yet.

Related content which might interest you: Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Sympathetic nervous system activation is an independent prognostic factor of clinical deterioration in pulmonary arterial hypertensive patients Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension Source: Annual Congress 2005 - Scientific year in review Year: 2005 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 704-705 Year: 2010 Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 792-794 Year: 2009 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Leptin signalling system as a target for pulmonary arterial hypertension therapy Source: Eur Respir J 2015; 45: 1066-1080 Year: 2015 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Primary pulmonary hypertension and endothelial dysfunction Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Is pulmonary hypertension associated with a leakage or an activation of endothelial cells? Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Expression of the serotonin 1b receptor in experimental pulmonary hypertension Source: Eur Respir J 2003; 22: 408-412 Year: 2003 Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Neuropeptides and the pulmonary vasculature Source: Annual Congress 2006 - Neurogenic inflammation – the link between nervous system and lung dysfunction Year: 2006